Hospital admissions related to acute exacerbations of chronic obstructive pulmonary disease in France, 1998-2007

Respiratory Medicine

Volumn 105, Issue 4, 2011, Pages 595-601

  Fuhrman, Claire ^a   Roche, Nicolas ^b   Vergnenègre, Alain ^c   Zureik, Mahmoud ^d   Chouaid, Christos ^e   Delmas, Marie Christine ^a  

^a INSTITUT DE VEILLE SANITAIRE   (France)

^b HÔTEL DIEU   (France)

^c Hopital du Cluzeau   (France)

^d INSERM   (France)

^e HÔPITAL SAINT ANTOINE   (France)

Author keywords

COPD; Epidemiology; Exacerbation; Hospitalization; Surveillance

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE EXACERBATION; FEMALE; FRANCE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL;

ADULT; AGED; COST-BENEFIT ANALYSIS; DISEASE PROGRESSION; FEMALE; FRANCE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 79952282954     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2010.11.014     Document Type: Article

References (37)

1. Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007;370:741-50. (Pubitemid 47321907)
2. Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM. Global burden of COPD: systematic review and meta-analysis. Eur Respir J 2006;28:523-32. (Pubitemid 44794666)
3. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007;370:765-73. (Pubitemid 47321908)
4. Sullivan SD, Ramsey SD, Lee TA. The economic burden of COPD. Chest 2000;117:5S-9S.
5. Detournay B, Pribil C, Fournier M, Housset B, Huchon G, Huas D, et al. The SCOPE study: health-care consumption related to patients with chronic obstructive pulmonary disease in France. Value Health 2004;7:168-74. (Pubitemid 38420729)
6. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global Strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176:532-55. (Pubitemid 47403272)
7. Biron E, Carre P, Chanez P, Crestani B, Cretin C, Dautzenberg B, et al. Le programme d'actions en faveur de la bronchopneumopathie chronique obstructive (BPCO): connaître, prévenir et mieux prendre en charge la BPCO. Rev Mal Respir 2006;23. 8S9-8S55.
8. Donaldson GC, Seemungal TA, Patel IS, Lloyd-Owen SJ, Wilkinson TM, Wedzicha JA. Longitudinal changes in the nature, severity and frequency of COPD exacerbations. Eur Respir J 2003;22:931-6. (Pubitemid 37540644)
9. Esteban C, Quintana JM, Moraza J, Aburto M, Egurrola M, Espana PP, et al. Impact of hospitalisations for exacerbations of COPD on health-related quality of life. Respir Med 2009; 103:1201-8.
10. Fournier M, Tonnel AB, Housset B, Huchon G, Godard P, Verloet D, et al. Impact économique de la BPCO en France: étude SCOPE. Rev Mal Respir 2005;22:247-56.
11. Bourbeau J, Julien M, Maltais F, Rouleau M, Beaupre A, Begin R, et al. Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention. Arch Intern Med 2003;163:585-91. (Pubitemid 36314346)
12. Casas A, Troosters T, Garcia-Aymerich J, Roca J, Hernandez C, Alonso A, et al. Integrated care prevents hospitalisations for exacerbations in COPD patients. Eur Respir J 2006;28:123-30. (Pubitemid 44914269)
13. Fuhrman C, Delmas MC. Hospitalisations pour exacerbations de BPCO: comment les identifier à partir des données du programme de médicalisation des systèmes d'information?. Saint-Maurice (France): Institut de veille sanitaire; 2009.
14. Réseau Sentinelles, INSERM, UPCM. Available from: http://www.sentiweb.fr [accessed 2010 May].
15. Fosse S, Hartemann-Heurtier A, Jacqueminet S, Ha VG, Grimaldi A, Fagot-Campagna A. Incidence and characteristics of lower limb amputations in people with diabetes. Diabet Med 2009;26:391-6.
16. Pascal L, Fuhrman C, Durif L, Nicolau J, Charpin D, Dujols P, et al. Evolution des hospitalisations pour asthme en France métropolitaine, 1998-2002. Rev Mal Respir 2007;24:581-90.
17. Piquet J, Chavaillon JM, David P, Martin F, Braun D, Ferrer LP, et al. Caractéristiques et prise en charge des exacerbations aiguës de BPCO hospitalisées. Etude EABPCO-CHPG du Collège des pneumologues des hôpitaux généraux. Rev Mal Respir 2010;27:19-29.
18. Roche N, Zureik M, Soussan D, Neukirch F, Perrotin DThe Urgence BPCO (COPD Emergency) Scientific Committee and investigators. Predictors of outcomes in COPD exacerbation cases presenting to the emergency department. Eur Respir J 2008;32:953-61.
19. Bustamante-Fermosel A, De Miguel-Yanes JM, Duffort-Falco M, Munoz J. Mortality-related factors after hospitalization for acute exacerbation of chronic obstructive pulmonary disease: the burden of clinical features. Am J Emerg Med 2007;25: 515-22. (Pubitemid 46818847)
20. Chen Y, Stewart P, Dales R, Johansen H, Bryan S, Taylor G. Changing age-pattern of hospitalisation risk of chronic obstructive pulmonary disease in men and women in Canada. Age Ageing 2005;34:373-7. (Pubitemid 41518705)
21. Holguin F, Folch E, Redd SC, Mannino DM. Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001. Chest 2005;128:2005-11.
22. Hansell A, Hollowell J, McNiece R, Nichols T, Strachan D. Validity and interpretation of mortality, health service and survey data on COPD and asthma in England. Eur Respir J 2003;21: 279-86. (Pubitemid 36204543)
23. Johnston NW. The similarities and differences of epidemic cycles of chronic obstructive pulmonary disease and asthma exacerbations. Proc Am Thorac Soc 2007;4:591-6. (Pubitemid 350291619)
24. Papi A, Bellettato CM, Braccioni F, Romagnoli M, Casolari P, Caramori G, et al. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med 2006;173:1114-21. (Pubitemid 43726892)
25. Seemungal T, Harper-Owen R, Bhowmik A, Moric I, Sanderson G, Message S, et al. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;164:1618-23. (Pubitemid 33124148)
26. Hutchinson AF, Ghimire AK, Thompson MA, Black JF, Brand CA, Lowe AJ, et al. A community-based, time-matched, case-control study of respiratory viruses and exacerbations of COPD. Respir Med 2007;101:2472-81. (Pubitemid 47618387)
27. Schembri S, Morant S, Winter JH, MacDonald TM. Influenza but not pneumococcal vaccination protects against all-cause mortality in patients with COPD. Thorax 2009;64:567-72.
28. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance - United States, 1971e2000. MMWR Surveill Summ 2002;51:1-16.
29. Agence de la santé publique du Canada. la vie et le souffle: les maladies respiratoires au Canada, 2007. Ottawa: Agence de la santé publique du Canada; 2007.
30. Trerotoli P, Bartolomeo N, Moretti AM, Serio G. Hospitalisation for COPD in Puglia: the role of hospital discharge database to estimate prevalence and incidence. Monaldi Arch Chest Dis 2008;69:94-106.
31. Wilson DH, Tucker G, Frith P, Appleton S, Ruffin RE, Adams RJ. Trends in hospital admissions and mortality from asthma and chronic obstructive pulmonary disease in Australia, 1993-2003. Med J Aust 2007;186:408-11.
32. Hill C, Laplanche A. Le tabac en France: les vrai chiffres. Paris: La documentation Française; 2003. 140 pp.
33. Chapman KR, Mannino DM, Soriano JB, Vermeire PA, Buist AS, Thun MJ, et al. Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J 2006;27:188-207. (Pubitemid 43092683)
34. Fuhrman C, Jougla E, Nicolau J, Eilstein D, Delmas MC. Chronic obstructive pulmonary disease deaths in France, 1979-2002: a multiple-cause analysis. Thorax 2006;61:930-4.
35. Delmas MC, Fuhrman C. L'asthme en France: synthèse des données épidémiologiques descriptives. Rev Mal Respir 2010; 27:151-9.
36. Brochard L, Mancebo J, Wysocki M, Lofaso F, Conti G, Rauss A, et al. Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. N Engl J Med 1995; 333:817-22.
37. Lightowler JV, Wedzicha JA, Elliott MW, Ram FSF. Non-invasive positive pressure ventilation to treat respiratory failure resulting from exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review and meta-analysis. BMJ 2003;326:185.